Clinical Trial Update: Identify Proteomic Biomarkers for Outcome Prediction of Locoregional Treatments for HCC

View source ↗

Summary

This completed clinical trial investigated proteomic biomarkers to predict outcomes after locoregional treatments in hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Hepatocellular Carcinoma | Status: COMPLETED